A new study published in Science estimates that roughly half of the variation in human lifespan is determined by genetics, nearly doubling the figure that researchers have accepted for decades. The finding, drawn from large Scandinavian twin registries and a U.S. dataset of centenarian families, challenges a long-standing consensus that genes account for only 20 to 25 percent of how long people live. If the higher estimate holds up to scrutiny, it could reshape how scientists prioritize genetic research in the study of aging.
Why Earlier Estimates Fell Short
For more than 30 years, the field of longevity genetics relied on a handful of twin studies to set expectations about heritability. One of the most cited, a 1993 analysis of Danish twins born between 1870 and 1880, placed the heritability of lifespan at roughly 0.33. Later meta-analyses pushed the consensus estimate even lower, settling in the range of 20 to 25 percent, according to the new paper’s own summary of prior work.
The problem, the new study argues, is that those earlier calculations treated all deaths the same. A person killed in a workplace accident at age 30 and a person who died of organ failure at 90 were both counted as data points in the same statistical model. Because random external causes of death, such as infections, violence, and accidents, dilute the genetic signal, conventional twin analyses systematically underestimated how much DNA matters for aging itself. Cohorts born in the late 1800s were especially affected, given the high rates of infectious disease and war-related mortality during their lifetimes.
Separating Biology From Bad Luck
The new research team tackled this bias by building mathematical mortality models that distinguish between two categories of death. “Extrinsic” mortality covers causes largely outside a person’s biological control, including accidents, epidemics, and armed conflict. “Intrinsic” mortality captures the gradual biological decline that genes influence most directly. By modeling these components separately across multiple large Scandinavian twin cohorts and a U.S. centenarian-sibling dataset, the researchers arrived at a heritability estimate of about 50 percent for the biological component of lifespan.
A separate summary of the findings in Nature placed the figure at approximately 55 percent, reflecting the upper bound of the study’s range once extrinsic mortality was fully accounted for. Either way, the gap between the old consensus and the new estimate is striking. It suggests that genes play a far larger role in determining who ages slowly and who ages quickly than most public health messaging has implied.
Family Clusters of Extreme Longevity
Supporting evidence comes from research on families with exceptionally long-lived members. A U.S. family-based study found that siblings of centenarians enjoy excess survival odds across the entire life course, not just in old age. The subjects in that dataset were born in the late 1800s and early 1900s, and the survival advantage persisted even after adjusting for shared environmental factors like household income and diet. That pattern, where extreme longevity clusters within families, is difficult to explain without a strong genetic component.
Broader reviews of genetics and healthy aging have also pointed to epigenetic mechanisms and somatic mosaicism as areas where inherited variation could shape how cells deteriorate over time. While no single “longevity gene” has been identified, the cumulative weight of family studies and twin analyses suggests that many small genetic effects add up to a meaningful influence on aging trajectories.
What the Estimate Does Not Mean
Not everyone in the field is ready to accept the new number at face value. A peer-reviewed perspective piece responding to the study cautions that the 50 percent figure is an inferred heritability under a modeled construct, not a direct measurement of specific genes. In other words, the researchers did not identify particular DNA variants responsible for longer life. They inferred the genetic contribution by subtracting out a statistical estimate of extrinsic mortality, and the accuracy of that subtraction depends on assumptions baked into the model.
This distinction matters because heritability is a population-level statistic, not a personal prediction. Saying that 50 percent of lifespan variation is heritable does not mean that half of any individual’s lifespan is “locked in” by their genome. It means that, across a population, about half of the differences in how long people live can be traced to genetic differences rather than environmental ones. The remaining variation still comes from diet, exercise, medical care, pollution exposure, and plain chance.
Heritability estimates are also context-dependent. In a society where everyone has similar access to healthcare and nutrition, genetic differences loom larger in explaining who lives longer. In settings with stark inequalities in safety, sanitation, or medical treatment, environmental factors can swamp genetic influences. The Scandinavian populations used in the new analysis fall closer to the former scenario, which may inflate the apparent role of genes compared with more heterogeneous or resource-limited contexts.
Consequences for Aging Research
If the higher heritability estimate gains acceptance, it could redirect funding and attention within aging science. For decades, the modest 20-to-25 percent figure encouraged researchers to focus heavily on lifestyle interventions, since environment appeared to dominate. A 50 percent estimate flips that calculus, suggesting that genetic pathways deserve at least equal investment.
That shift carries practical implications. Drug development programs targeting biological aging, from senolytics that clear damaged cells to compounds that mimic caloric restriction, would gain stronger theoretical backing if the genetic architecture of aging turns out to be more influential than previously thought. Personalized medicine approaches that tailor interventions to a patient’s genetic risk profile would also become more attractive to funders and regulators.
Public health messaging may need recalibration as well. For years, campaigns have emphasized that lifestyle choices can “add years to your life,” sometimes downplaying the role of inherited risk. Acknowledging a larger genetic component does not negate the importance of behavior, but it does argue for more realistic expectations: some people may see dramatic gains from diet and exercise, while others with heavy genetic burdens might experience more modest benefits, even when they follow the same advice.
Limits of the New Analysis
At the same time, the study has clear limitations that temper any sweeping conclusions. The twin cohorts are overwhelmingly Scandinavian, meaning the results may not generalize to populations with different genetic backgrounds, disease environments, or healthcare systems. The centenarian-sibling dataset is U.S.-based but still relatively narrow in socioeconomic and ethnic representation. Extrapolating a 50 percent heritability figure to the entire globe would be premature.
The distinction between extrinsic and intrinsic mortality, while conceptually useful, is not always clean in practice. Many causes of death, such as chronic infections or complications from long-term occupational exposures, blur the line between external hazards and internal vulnerability. If the model misclassifies some of these deaths, the estimated genetic contribution to intrinsic mortality could be biased upward or downward.
Moreover, the new estimate does not resolve the “missing heritability” problem in aging research. Genome-wide association studies have so far explained only a small fraction of lifespan variation through identified variants. If genes truly account for roughly half the differences in how long people live, most of the responsible variation remains hidden in complex interactions, rare variants, or regulatory regions that current methods struggle to detect.
What Comes Next
Going forward, independent groups will need to test the study’s modeling approach on other large datasets, including cohorts from regions with very different mortality patterns. Linking genetic data to detailed life histories and cause-of-death records could help refine the separation between extrinsic and intrinsic risks. As more biobanks mature and as statistical tools improve, researchers may be able to move beyond aggregate heritability estimates toward pinpointing specific biological pathways that drive slow or rapid aging.
For now, the new work serves mainly as a provocation: a reminder that the balance between nature and nurture in human longevity is still being negotiated. If genetics truly explains closer to half, rather than a quarter, of lifespan variation, the stakes for understanding the biology of aging are higher than many had assumed. But even under the most gene-heavy scenarios, environment and chance retain enormous influence, ensuring that no DNA sequence can fully script how long any individual life will be.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
